Literature DB >> 16148175

Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative and gram-positive infections in leukopenic rats.

Eva Tavares1, Rosario Maldonado, Maria L Ojeda, Francisco J Miñano.   

Abstract

Gram-negative and gram-positive infections have been considered the most important causes of morbidity and mortality in patients with leukopenia following chemotherapy. However, discrimination between bacterial infections and harmless fever episodes is difficult. Because classical inflammatory signs of infection are often absent and fever is frequently the only sign of infection, the aim of this study was to assess the significance of serum interleukin-6 (IL-6), IL-10, macrophage inflammatory protein-2 (MIP-2), procalcitonin (PCT), and C-reactive protein (CRP) patterns in identifying bacterial infections during start of fever in normal and cyclophosphamide-treated (leukopenic) rats following an injection of lipopolysaccharide (LPS) or muramyl dipeptide (MDP) as a model for gram-negative and gram-positive bacterial infections. We found that, compared to normal rats, immunosuppressed animals exhibited significantly higher fevers and lesser production of all mediators, except IL-6, after toxin challenge. Moreover, compared to rats that received MDP, both groups of animals that received an equivalent dose of LPS showed significantly higher fevers and greater increase in serum cytokine levels. Furthermore, in contrast to those in immunocompetent rats, serum levels of IL-6 and MIP-2 were not significantly changed in leukopenic animals after MDP injection. Other serum markers such as PCT and CRP failed to discriminate between bacterial stimuli in both groups of animals. These results suggest that the use of the analyzed serum markers at an early stage of fever could give useful information for the clinician for excluding gram-negative from gram-positive infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148175      PMCID: PMC1235789          DOI: 10.1128/CDLI.12.9.1085-1093.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  42 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults.

Authors:  L Bernard; F Ferrière; P Casassus; F Malas; S Lévêque; L Guillevin; O Lortholary
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

3.  Gram-positive and gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways.

Authors:  L Rabehi; T Irinopoulou; B Cholley; N Haeffner-Cavaillon; M P Carreno
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia.

Authors:  T A Madani
Journal:  Infection       Date:  2000 Nov-Dec       Impact factor: 3.553

5.  Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.

Authors:  M Soker; L Colpan; A Ece; C Devecioğlu; K Haspolat
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

6.  Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.

Authors:  S M Opal; A S Cross; J C Sadoff; H H Collins; N M Kelly; G H Victor; J E Palardy; M W Bodmer
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

7.  The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.

Authors:  C A Dinarello; R J Elin; L Chedid; S M Wolff
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

8.  Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia.

Authors:  P Engervall; B Andersson; M Björkholm
Journal:  Br J Haematol       Date:  1995-12       Impact factor: 6.998

9.  Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver.

Authors:  Harmeet Malhi; Pallavi Annamaneni; Sanjeev Slehria; Brigid Joseph; Kuldeep K Bhargava; Christopher J Palestro; Phyllis M Novikoff; Sanjeev Gupta
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

10.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

View more
  17 in total

1.  Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients.

Authors:  Pierre Emmanuel Charles; Frédéric Dalle; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Hervé Aube; Nils-Olivier Olsson; Bernard Blettery
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

2.  Prior infections are associated with increased mortality from subsequent blood-stream infections among patients with hematological malignancies.

Authors:  J A Greenberg; M Z David; D L Pitrak; J B Hall; J P Kress
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-03       Impact factor: 3.267

3.  Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit.

Authors:  Filippo Pieralli; Lorenzo Corbo; Arianna Torrigiani; Dario Mannini; Elisa Antonielli; Antonio Mancini; Francesco Corradi; Fabio Arena; Alberto Moggi Pignone; Alessandro Morettini; Carlo Nozzoli; Gian Maria Rossolini
Journal:  Intern Emerg Med       Date:  2017-02-04       Impact factor: 3.397

4.  Deletion of the gene encoding calcitonin and calcitonin gene-related peptide α does not affect the outcome of severe infection in mice.

Authors:  Michael J Tuvim; Cecilia G Clement; Eileen Su-Chen Huang; Gilbert J Cote; Scott E Evans; Xiudong Lei; Leonard J Deftos; Robert F Gagel; Burton F Dickey
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

5.  Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay.

Authors:  Iraklis Tsangaris; Diamantis Plachouras; Dimitra Kavatha; George Michael Gourgoulis; Argirios Tsantes; Petros Kopterides; George Tsaknis; Ioanna Dimopoulou; Stylianos Orfanos; Evangelos Giamarellos-Bourboulis; Helen Giamarellou; Apostolos Armaganidis
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

6.  Lipoprotein lipase and hydrofluoric acid deactivate both bacterial lipoproteins and lipoteichoic acids, but platelet-activating factor-acetylhydrolase degrades only lipoteichoic acids.

Authors:  Ho Seong Seo; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

7.  A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections.

Authors:  Ashwini Chauhan; David Lebeaux; Benoit Decante; Irene Kriegel; Marie-Christine Escande; Jean-Marc Ghigo; Christophe Beloin
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

8.  Elevated Serum PCT in Septic Shock With Endotoxemia Is Associated With a Higher Mortality Rate.

Authors:  Barbara Adamik; Jakub Smiechowicz; Dominika Jakubczyk; Andrzej Kübler
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

9.  Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients.

Authors:  Junyan Qu; Xiaoju L; Yanbin Liu; Xiaohui Wang
Journal:  Indian J Med Res       Date:  2015-03       Impact factor: 2.375

10.  Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria.

Authors:  Pierre Emmanuel Charles; Sylvain Ladoire; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Sébastien Prin; Niels-Olivier Olsson; Bernard Blettery
Journal:  BMC Infect Dis       Date:  2008-03-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.